Dr. Michael Kofi Adusei, MD

Dr. Adusei practices at Stamford Hospital in Stamford, Connecticut.

Dr. Adusei's NPI, 1043560287, was assigned on September 14, 2012. Dr. Adusei holds Connecticut license 051379.

Dr. Adusei's primary practice is Stamford Hospital, at 1 Hospital Plz, Stamford, CT 06902 in Western Ct County. The practice phone is (203) 276-1000.

Dr. Adusei's primary practice is Stamford Hospital in Stamford, Connecticut. Dr. Adusei is also affiliated with Stamford Hospital. The medical group on file is Stamford Health Medical Group. Dmand AI also links Dr. Adusei to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Adusei practices, 4 sites in all. Vendor and product names are available with a free account.

Addiction psychiatry is Dr. Adusei's primary specialty in the NPI Registry, under taxonomy code 2084P0802X. Dmand AI has Dr. Adusei's licenses on file in 2 states: Connecticut and California.

CMS data shows 170 Medicare services from Dr. Adusei across 3 procedure codes in 2024, for 87 Medicare patients. Medicare paid $12,761 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 87 Medicare patients who saw Dr. Adusei in 2024. The largest group is under 65, with 46 patients. 75% of them have high blood pressure, and 75% have mood disorders. 79% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Adusei's median patient age at 36, with 50% women.

In 2024, Dr. Adusei wrote 1,424 Medicare Part D claims for 76 patients. 94% of them were for generic drugs. CMS names the drug for 1,232 of them, across 34 drugs with 11 or more claims each, at $200,342 in total drug cost. In 2023, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Adusei for performance year 2024, reported as part of a group. Dr. Adusei accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Adusei as offering telehealth.

CMS Open Payments shows 7 general payments to Dr. Adusei from 1 drug or device company from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $477.